Cost Pressures Cut Into Ardent’s Outlook

The health system’s leaders say increases in professional fees and insurer denials unexpectedly ticked up in the third quarter, after appearing to stabilize earlier in the year
Nov. 13, 2025
3 min read

Key Highlights

  • Shares of Ardent Health fell nearly 34 percent after announcing a significant profit forecast reduction due to rising costs and claims denials.
  • The company is renegotiating vendor contracts and replacing locums with full-time staff to control costs amid industry headwinds.
  • Ardent has laid off employees and negotiated labor contracts to save over $40 million annually, aiming to strengthen financial stability.
  • Third-quarter net profit dropped to $1.2 million from $46 million, despite a 9 percent revenue increase to $1.58 billion.
  • Looking ahead, Ardent plans to expand its network with new ambulatory surgery centers, urgent-care clinics, and a freestanding emergency department in 2026.

Shares of Ardent Health Inc. lost a third of their value Nov. 13 after the health system operator’s executives said rising professional fees and claims denials would help slash its 2025 net profits by half.

Speaking to analysts after Nashville-based Ardent reported its third-quarter results, President and CEO Marty Bonick said costs to bring in providers—most notably in anesthesia and radiology—have climbed faster this year than his team had expected. Professional fees were up 6 percent year over year in the first quarter—an improvement from last year’s 12 percent—but that pace accelerated in the spring to 9 percent and again in the three months that ended Sept. 30 to 11 percent.

That trend has moved Ardent’s leaders, who oversee 30 hospitals and 280 sites of care in six states, to respond beyond lowering their profit-growth forecast.

“We are renegotiating certain vendor contracts, particularly in anesthesia, to introduce more flexible cost structures that better align with patient volumes,” Bonick said on a conference call. “Additionally, given our increased scale, we are strategically replacing locums with more cost-efficient full-time hires. Collectively, these initiatives are strengthening the organization and will better position us for future earnings growth.”

Along with rising professional fees, healthcare providers have in recent quarters faced a growing number of claims denials from insurers, who argue that hospitals and clinics are being overly aggressive in their coding of procedures. Bonick said Ardent teams faced an unexpected Q3 uptick in denials after they had appeared to stabilize in the first of this year and that its outlook now “prudently assumes these industry headwinds observed in the third quarter will persist at elevated levels in the fourth quarter.”

Alongside the work underway to address professional fees, Ardent has created a group to address its insurance contracts and claims processes. In addition to those initiatives, Ardent executives recently laid off some employees and negotiated down an agency labor contract. Bonick said those moves will save the company more than $40 million on an annual basis.

Ardent shares (Ticker: ARDT) fell nearly 34 percent to $9.30 after the earnings report and conference call. At that level, they’re more than 40 percent below the level at which Ardent went public in the summer of 2024. The company’s market capitalization is now about $1.3 billion.

During the third quarter, Ardent produced a net profit of $1.2 million, down from about $46 million in the same period of last year, as revenues rose nearly 9 percent to $1.58 billion. In addition to the cost pressures discussed above, the lower income comprises a $54 million the company needed to add to its liability reserves related to claims involving a New Mexico doctor who’s no longer with the company.

Bonick and CFO Alfred Lumsdaine have lowered their profitability targets for the year: Net income is now forecast to be between $121 million and $146 million (versus their previous outlook of $245 million to $285 million) while adjusted EBITDA is now expected to be $530 million to $555 million, roughly $45 million lower than before.

But they pointed out to analysts that Ardent will still grow its earnings before interest, taxes, depreciation and amortization versus 2024 and that they expect consistent growth over the longer term. Ardent’s Q3 showed increases in adjusted admissions (2.9 percent), total surgeries (1.4 percent) and net patient revenue per adjusted admission (5.8 percent).

Looking ahead to 2026, Ardent’s executives said they plan to add to their network two ambulatory surgery centers, four urgent-care clinics and one freestanding emergency department.

About the Author

Geert De Lombaerde

A native of Belgium, Geert De Lombaerde has more than two decades of business journalism experience and writes about markets and economic trends for Endeavor Business Media publications Healthcare InnovationIndustryWeek, FleetOwner, Oil & Gas Journal and T&D World. With a degree in journalism from the University of Missouri, he began his reporting career at the Business Courier in Cincinnati and later was managing editor and editor of the Nashville Business Journal. Most recently, he oversaw the online and print products of the Nashville Post for more than a decade and reported primarily on Middle Tennessee’s finance sector as well as many of its publicly traded companies.

Sign up for our eNewsletters
Get the latest news and updates